发明名称 |
Trimeric HIV Fusion Inhibitors for Treating or Preventing HIV Infection |
摘要 |
Disclosed herein are trimeric polypeptide pharmaceutical compositions comprising three monomers, each monomer comprising a polypeptide having the amino acid sequence of the N-terminal heptad repeat (NHR or HR1) or C-terminal heptad repeat (CHR or HR2) of the transmembrane glycoprotein of human immunodeficiency virus (HIV) and a trimerization motif. |
申请公布号 |
US2015306174(A1) |
申请公布日期 |
2015.10.29 |
申请号 |
US201514796725 |
申请日期 |
2015.07.10 |
申请人 |
New York Blood Center |
发明人 |
Jiang Shibo;Qi Zhi;Chen Xi;Pan Chungen |
分类号 |
A61K38/16;C12N7/00 |
主分类号 |
A61K38/16 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of inhibiting the fusion of a human immunodeficiency virus (HIV) to a target cell comprising:
administering a trimeric polypeptide pharmaceutical composition to the target cells, wherein the composition comprises a trimeric polypeptide, wherein the trimeric polypeptide comprises three polypeptide monomers, each polypeptide monomer consisting of a fusion peptide consisting of the amino acid sequence of the N-terminal heptad repeat (NHR or HR1) of the transmembrane glycoprotein gp41 of HIV fused to a foldon trimerization motif, wherein the NHR is N28, and wherein the foldon trimerization motif sequence is fused to the C-terminus of the NHR; and inhibiting fusion of the virus to the cell. |
地址 |
New York NY US |